Childhood Hemolytic Uremic Syndrome, United Kingdom and Ireland
- 1 April 2005
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 11 (4), 590-596
- https://doi.org/10.3201/eid1104.040833
Abstract
We conducted prospective surveillance of childhood hemolytic uremic syndrome (HUS) from 1997 to 2001 to describe disease incidence and clinical, epidemiologic and microbiologic characteristics. We compared our findings, where possible, with those of a previous study conducted from 1985 to 1988. The average annual incidence of HUS for the United Kingdom and Ireland (0.71/100,000) was unchanged from 1985 to 1988. The overall early mortality had halved, but the reduction in mortality was almost entirely accounted for by improved outcome in patients with diarrhea-associated HUS. The principal infective cause of diarrhea-associated HUS was Shiga toxin–producing Escherichia coli O157 (STEC O157), although in the 1997–2001 survey STEC O157 phage type (PT) 21/28 had replaced STEC O157 PT2 as the predominant PT. The risk of developing diarrhea-associated HUS was significantly higher in children infected with STEC O157 PT 2 and PT 21/28 compared with other PTs. Hypertension as a complication of HUS was greatly reduced in patients with diarrhea-associated HUS.Keywords
This publication has 17 references indexed in Scilit:
- Surveillance for rare disorders by the BPSUArchives of Disease in Childhood, 2002
- Clinical Course and the Role of Shiga Toxin–ProducingEscherichia coliInfection in the Hemolytic‐Uremic Syndrome in Pediatric Patients, 1997–2000, in Germany and Austria: A Prospective StudyThe Journal of Infectious Diseases, 2002
- The Central ScotlandEscherichia coliO157:H7 Outbreak: Risk Factors for the Hemolytic Uremic Syndrome and Death among Hospitalized PatientsClinical Infectious Diseases, 2001
- Nationwide study of haemolytic uraemic syndrome: clinical, microbiological, and epidemiological featuresArchives of Disease in Childhood, 2001
- The United States National Prospective Hemolytic Uremic Syndrome Study: Microbiologic, Serologic, Clinical, and Epidemiologic FindingsThe Journal of Infectious Diseases, 2001
- The serodiagnosis of infections caused by Verocytotoxin‐producingEscherichia coliJournal of Applied Microbiology, 1999
- Hemolytic uremic syndrome in Belgium: incidence and association with verocytotoxin-producing Eschevichia coli infectionClinical Microbiology & Infection, 1999
- Serological identification of Escherichia coli 0157:H7 infection in haemolytic uraemic syndromeThe Lancet, 1991
- Haemolytic uraemic syndromes in the British Isles 1985-8: association with verocytotoxin producing Escherichia coli. Part 1: Clinical and epidemiological aspects.Archives of Disease in Childhood, 1990
- Toxin Genotypes and Plasmid Profiles as Determinants of Systemic Sequelae in Escherichia coli O157:H7 InfectionsThe Journal of Infectious Diseases, 1989